logo
  • 首页
  • 学术期刊
  • 论文检测
  • AIGC检测
  • 热点
  • 更多
    • 数据

Ipilimumab/pembrolizumabAutoimmune colitis and pancreatitis: case report

被引:0
|
作者:
机构:
来源:
Reactions Weekly | 2016年 / 1617卷 / 1期
关键词:
D O I:
10.1007/s40278-016-20924-1
中图分类号:
学科分类号:
摘要:
引用
收藏
页码:145 / 145
相关论文
共 50 条
  • [1] Ipilimumab/pembrolizumabAutoimmune colitis, immune-mediated arthritis and pancreatitis: case report
    Reactions Weekly, 2020, 1799 (1) : 236 - 236
  • [2] Ipilimumab/pembrolizumabAutoimmune colitis and acute lymphocytic gastritis: case report
    Reactions Weekly, 2020, 1831 (1) : 172 - 172
  • [3] PembrolizumabAutoimmune mediated acute pancreatitis and colitis: case report
    Reactions Weekly, 2020, 1793 (1) : 371 - 371
  • [4] Ipilimumab/pembrolizumabAutoimmune diabetes: case report
    Reactions Weekly, 2019, 1784 (1) : 158 - 158
  • [5] PembrolizumabAutoimmune colitis: case report
    Reactions Weekly, 2021, 1863 (1) : 285 - 285
  • [6] PembrolizumabAutoimmune colitis: case report
    Reactions Weekly, 2020, 1797 (1) : 196 - 196
  • [7] Bevacizumab/pembrolizumabAutoimmune pancreatitis: case report
    Reactions Weekly, 2023, 1959 (1) : 144 - 144
  • [8] PembrolizumabAutoimmune arthritis and colitis: case report
    Reactions Weekly, 2020, 1817 (1) : 269 - 269
  • [9] PembrolizumabAutoimmune colitis and orchitis: case report
    Reactions Weekly, 2018, 1731 (1) : 209 - 209
  • [10] Ipilimumab/pembrolizumabAutoimmune hepatitis and adrenal crisis: case report
    Reactions Weekly, 2018, 1687 (1) : 124 - 124
← 12345 →